Shambhavi, S. (2025) “Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis”, World Journal of Oncology, 16(4), pp. 331–341. doi:10.14740/wjon2613.